Jason McCarthy Profile - Maxim Group Analyst

9,202 Followers
tipranks
Jason McCarthy

Jason McCarthy
Maxim Group

Wall Street Analyst
#8,509 out of 8,562 Wall Street Analysts
#34,508 out of 34,860 experts

Success Rate

22%
108 out of 499 ratings made a profit

Average Return

-29.90%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Jason McCarthy's trades since 2015 and holding each position for 1 Year would result in 21.64% of your transactions generating a profit, with an average return of -29.9% per rating.

Stock Rating Distribution

3KRatings
87.89% Buy
11.53% Hold
0.58% Sell
Distribution of Jason McCarthy's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market
CanadaCanadian Market
United KingdomUK Market

Best Rating

Stock:
Reviva Pharmaceuticals Holdings, Inc.
(RVPH)
Rating:Buy
Date:Aug 16, 2022 - Aug 16, 2023
Return:+451.70%
The most profitable rating made by Jason McCarthy

Jason McCarthy's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Celyad Oncology
Dec 01, 2015
Buy
Reiterated
$100.00
4Ratings
0.00%
Acer Therapeutics
Oct 28, 2016
Hold
Downgraded
12Ratings
0.00%
Savara
Apr 19, 2017
Hold
Assigned
13Ratings
0.00%
Bavarian Nordic
May 05, 2017
Buy
Reiterated
13Ratings
0.00%
Agenus
May 08, 2017
Buy
Reiterated
$7.00
(493.22% Upside)
12Ratings
0.00%
Edesa Biotech
May 10, 2017
Buy
Reiterated
$2.00
(134.71% Upside)
12Ratings
0.00%
Bio-Path Holdings
May 15, 2017
Buy
Reiterated
$20.00
(5139.72% Upside)
5Ratings
0.00%
Oncotelic Therapeutics
Aug 01, 2017
Hold
Reiterated
6Ratings
0.00%
MNTA
Momenta Pharma
Aug 03, 2017
Sell
Reiterated
12Ratings
0.00%
NovaBay Pharma
Aug 11, 2017
Hold
Reiterated
2Ratings
0.00%
List of latest recommendations made by Jason McCarthy. Click to expand and see Jason McCarthy's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

Jason McCarthy activity FAQ

What is the performance of Jason McCarthy's recommendations?
The percentage of profitable recommendations made by Jason McCarthy is 22%, and the average return per transaction is -29.90%.
    What stocks does Jason McCarthy cover?
    Jason McCarthy mostly covers INO , SLS , IMMP stocks.
      What was Jason McCarthy’s latest rating?
      Jason McCarthy latest rating was a hold on BNTC with a price target of ―, which represents an Upside of ―
        What was Jason McCarthy's most profitable rating?
        Jason McCarthy’s most profitable ratings was a buy on RVPH stock on Aug 16, 2022 - Aug 16, 2023. The return on the trade was +451.70%.
          Where can I see a list of stock analyst ratings?
          You can see a list of daily stock analyst ratings here.
            What are the most recommended stocks by analysts?
            You can see a list of the most recommended stocks by analysts here